jp_master

@sportfun @AdamFDF_ 1. Are revenues disclosed somewhere officially? 2. What percentage of revenues goes towards buybacks? 3. Have buybacks been started? If so how can we verify them? 4. How do you ensure that buybacks will not enter circulation again? Considering burnings maybe?

To kick things off for WC26, we're hosting an AMA tomorrow at 12 PM UTC. Got questions for @AdamFDF_? Drop them below 👇

@SeiBull @sportfun A couple of questions from my side on $FUN? 1. Are revenues disclosed somewhere officially? 2. What percentage of revenues goes towards buybacks? 3. Have buybacks been started? If so how can we verify them?

reasons I'm maxbidding $FUN @sportfun: - ansem telling you its base szn - biggest world cup ever starts in 3 weeks time - backed by coinbase ventures - listed on coinbase - actual product with good revenue - not even back to ATH yet easy bid imo

@0xbasemafia @base Both of them are already in top100

$VVV is now the 2nd biggest coin on @base $VIRTUAL still hasn't had a major pump since the start of 2026 and is trading around $0.7 - $1 $AERO is also mispriced right now as the #1 liquidity engine on base both $VIRTUAL and $AERO should enter the top 100 soon

@0xkioto @n0commas @dphnAI Can I buy $POD from LBANK CEX? or it'd not the same contract?

@n0commas @dphnAI 🫡

Dolphin AI (@dphnAI) / $pod is like early bitcoin narrative decentralized distributed inference paired with uncensored model sooner or later, regulation across the globe will limit all the frontier models from SOTA labs probably a product that can break into the masses globally the vision is everyone turning their gpu mining rigs into nodes on dolphin network two good reads: x.com/0xkioto/status… x.com/sapphycrypto/s…

@David0006140892 @TimeFreedomROB Which app is this?

@TimeFreedomROB Price Forecast saying $VVV is coming to around $27 soon.

$VVV 1D Here comes the Giant Green Volume Candles Expect them to continue Then we should see a giant red candle to mark the top

@Dansfera When is the meeting A minutes from FDA? I though soon

@giannispanos whenever the start and finish the studies

The way I buy more $iova $aqst and $atai at same time

@Dansfera In what percentages you have those 3 in your portfolio? 33.3% each or you are heavier in one of them?

Three things to watch in biotech this month: $IOVA Q1 (May 7), $AQST FDA Type A minutes (early May), $ATAI Phase 3 start (Q2). One launch, one resub, one pivotal. Different timelines, same question, can the science get to commercial scale.

@chrisfas_61 Πληρωμενα τρολ είναι!

Δεν είναι ανάγκη να διαβάσει κανείς στο διαδίκτυο τις χυδαίες επιθέσεις στη νεαρή γιατρό για να διαπιστώσει ότι τα χειρότερα καθάρματα δεν είναι αυτοί που μας κυβερνούν. Τα χειρότερα καθάρματα είναι οι ψηφοφόροι τους.

@MarkissiosK Πληρωμενα τρολς είναι αυτοί οι λογαριασμοί! Κανένας νοημον άνθρωπος δεν την βρίζει!

Ένα νέο κορίτσι κλαίει από το burnout και τα ζώα οι οπαδοί της κυβέρνησης την βρίζουν μέρα νύχτα.

@protothema Αυτό σας είπε να γράψετε? Είστε ότι πιο σιχαμερο σε ΜΜΕ!!

«Καμία υπερεργασία, είδε 19 παιδιά» λέει ο Γεωργιάδης για την ειδικευόμενη που κατήγγειλε πως εφημέρευε 5 συνεχόμενες ημέρες #protothema #Echobox=1777470553" target="_blank" rel="nofollow noopener">protothema.gr/politics/artic…

@AdonisGeorgiadi @YannisKaramits @XaLaRa_Se_Lew Όταν τα πρόσωπα είναι ΕΞΑΙΡΕΤΙΚΆ στην δουλειά τους τότε εννοείται και να μένουν ισόβια στην θέση τους!

@YannisKaramits @XaLaRa_Se_Lew Δεν έχω δηλ δικαίωμα να ζητάω να κριθεί η ερμηνεία του Κανονισμού που δίνει σε αυτόν η κα Κοβέσι και οδηγεί στην ισόβια ανανέωση των ίδιων προσώπων στην Ευρωπαϊκή Εισαγγελία από του Ευρωπαϊκό Δικαστήριο; Ωραίος Φιλελεύθερος Ευρωπαϊστής είστε

Ευρωπαϊκή Εισαγγελία και σταλινισμός στην ίδια πρόταση. Καλά το πάτε.

@mkaristianou Μαζί σου Μαρία!!! Μέχρι τέλους!!!

Ξεκινάμε πρώτη του μήνα για την πρωτιά στη δράση για ΑΛΗΘΕΙΑ και ΔΙΚΑΙΟΣΥΝΗ! Από το «Εγώ» στο «Εμείς» Υπάρχουν στιγμές στην ιστορία ενός τόπου που η σιωπή γίνεται πιο βαριά από την ίδια την αδικία. Σε μια τέτοια στιγμή, επιλέξαμε να μιλήσουμε. Όχι γιατί είναι εύκολο, αλλά γιατί είναι το μόνο που μπορεί να μας κρατήσει όρθιους και να διατηρήσει την ΕΛΠΙΔΑ ζωντανή. Το κίνημα αυτό δεν γεννήθηκε σε στείρους τόπους. Γεννήθηκε μέσα στις καρδιές των ανθρώπων που αρνήθηκαν να συμβιβαστούν με το σάπιο. Ξεκινάμε σήμερα ως μια αδιαπέραστη ΕΛΠΙΔΑ ΑΛΗΘΕΙΑΣ, ΔΙΚΑΙΟΣΥΝΗΣ & ΑΞΙΟΠΡΕΠΕΙΑΣ. Σας αναμένουμε με αγάπη στην πρώτη γραμμή! Γιατί το δίκαιο, όταν διεκδικείται με πίστη και ενότητα , δεν χάνει ποτέ! ΞΕΚΙΝΑΜΕ ΓΙΑ ΤΗΝ ΕΛΠΙΔΑ ! 
xekiname.gr

@Alpha_MEXC @HandlPay Finally a project with real utility!! $HANDL @HandlPay

MEXC New Listing with Airdrop+ & Earn Features: Share 2,000,000 $HANDL, 30,000 USDT & Extra Futures Bonuses Up for Grabs! ‣ $HANDL @HandlPay ‣ Trading: Mar 25, 2026, 13:00 (UTC)

@BIOTECHSCANNER @MyronGriffin12 Since $AQST has closer catalysts, isn't it wiser to stick with it and then move the profits post approval to $IOVA?

$IOVA has the best long term potential (2-5 years) than any biotech that I can think of. All you have to look at is the revenue and the pipeline. $IOVA will 10X from here easily within 3 years. It will be bought out by end of 2027 or sooner imo. $IOVA has the best pipeline in biotech.

$IOVA - Throughout the year, in any year, there will be domestic or international events that affect the macro market conditions. Most of the time these events have nothing to do with the company or the stock. Unfortunately during times of war (declare or undeclared) the stock price will be negatively impacted. It is up to us and our research to determine if anything has fundamentally changed with the company. For me, the current market condition is providing a huge opportunity to accumulate more shares. The only thing you need to do is to look further down the road. For $IOVA, it will be the leader of solid tumor treatments. As you know, solid tumor cancers make up 90% of all new cancers. The current market cap is $1.52B? Are you kidding me? Again, this will be $10 by end of year. By far this is the best biotech to own for the next 5 years. It’s not even close actually.

«Εγώ είμαι συνήγορος του κ. Ρούτσι τον οποίο ακολουθείτε και μου είπατε ότι έχετε οδηγίες από ψηλά. Εσείς ποιος είστε;», H Zωή @ZoeKonstant ξεμπροστιάζει ασφαλίτη που παρακολουθούσε από κοντά τον Πάνο Ρούτσι... Βίντεο @chris_avramidis

@HandlPay Bright future ahead for $HANDL

@HandlPay Congrats team!!!! 🔥🔥🔥🔥

$HANDL is listing on March 25! This is a multi-chain token and it will be available on the following chains as of listing: Base, Polygon (ERC-20) & Canton Network (CIP-56). ✅ Staking pools ✅ Token buybacks ✅ Tangible utility (gas token, access to premium and reward tiers) ✅ First project token on Canton Network with a CEX listing Listing + trading venues will be announced soon. Make sure to turn on your notifications. So why now? We intentionally waited to launch the token until the product had real usage. Instead of timing the market, we wanted token utility to be immediately connected to a working product. HandlPay has already passed the MVP stage and we’ve tested the system under significant load, at times over 100,000 transactions per day. The token isn’t launching into an idea, but into a product that people are already using. If the market happens to be bearish right now, that’s fine with us. It just means more upside ahead.

@BIOTECHSCANNER How would you split 100k between $IOVA and $AQST at the moment?

$IOVA - Wish granted. I have been in the industry for a long time. I know an anti pharma person when I see one. Dr. Prasad is a roadblock for innovation. He resigned. This time for good🤞.

@bbertagashii @TexasWoodpecker @DrMakaryFDA Usability failure is basically some people were not able to open to package. No issues with the drug. This gets approved next time 100%

FDA is moving with unprecedented agility. Today we approved a multiple myeloma drug just 55 days after the application was filed. And last week’s approval (a major leap forward) was approved in 44 days. If a trial result shows immediate promise for many Americans, why wait?